Hello All
This is just to let you know that the Scottish Medicines Consortium (SMC) has announced that rucaparib will be available as maintenance treatment for those with platinum-sensitive relapsed high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who do not have a BRCA mutation.
There is more information on the SMC website here:
scottishmedicines.org.uk/ab...
Best wishes
Julia (Support Services Officer)